Heng-Hsu Lin1, Chia-Sung Wang2, Jiunn-Lee Lin3, Juey-Jen Hwang3, Lian-Yu Lin3. 1. Cardiovascular Center, Far Eastern Memorial Hospital; 2. Department, of Internal Medicine, En Chu Kong Hospital; 3. Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract
OBJECTIVES: This study is designed to investigate the effects of anti-hypertensive monotherapy [either calcium channel blocker (CCB) or angiotensin receptor blocker (ARB)] on pulsatile hemodynamic parameters in patients with uncomplicated hypertension. METHODS: This is a longitudinal observational study. For simplicity, we included patients with uncomplicated hypertension who receivedmono anti-hypertensive therapy with ARB or CCB. Hemodynamic parameters including central arterial pressure (CAP), aortic characteristic impedance (Zc), augmentation index (AI), brachial-ankle pulse wave velocity (baPWV), heart-ankle pulse wave velocity (haPWV), cardiac ultrasonographic parameters and ventriculo-arterial (VA) coupling were measured before, 1 month and 3 months after treatment. RESULTS: A total of 74 subjects were included in our study for analysis from 2007-2008. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and central systolic arterial pressure (CSAP) were significantly reduced 1 and 3 months after initiation of therapy. Among the pulsatile hemodynamic parameters, only the baPWV was significantly reduced (from1537.78 ± 200.63 cm/s to 1460.06 ± 186.09 cm/s to 1456.53 ± 196.03 cm/s, p for trend = 0.016). The haPWV only decreased with borderline significance (from 1015.38 ± 124.26 cm/s to 978.88 ± 126.55 cm/s to 967.99 ± 103.37 cm/s, p for trend = 0.041). The other pulsatile hemodynamic parameters remained unchanged before and after therapy. Subgroup analysis (age above or below52 years) showed that the baPWVwas significantly reduced only in the younger group. CONCLUSIONS: Among the pulsatile hemodynamic parameters, only the baPWV was effectively reduced by either CCB or ARB. The improvement of PWV was more evident in younger subjects. KEY WORDS: Arterial stiffness; Central arterial pressure; Hypertension; Pulse wave velocity; Ventriculo-arterial coupling.
OBJECTIVES: This study is designed to investigate the effects of anti-hypertensive monotherapy [either calcium channel blocker (CCB) or angiotensin receptor blocker (ARB)] on pulsatile hemodynamic parameters in patients with uncomplicated hypertension. METHODS: This is a longitudinal observational study. For simplicity, we included patients with uncomplicated hypertension who receivedmono anti-hypertensive therapy with ARB or CCB. Hemodynamic parameters including central arterial pressure (CAP), aortic characteristic impedance (Zc), augmentation index (AI), brachial-ankle pulse wave velocity (baPWV), heart-ankle pulse wave velocity (haPWV), cardiac ultrasonographic parameters and ventriculo-arterial (VA) coupling were measured before, 1 month and 3 months after treatment. RESULTS: A total of 74 subjects were included in our study for analysis from 2007-2008. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and central systolic arterial pressure (CSAP) were significantly reduced 1 and 3 months after initiation of therapy. Among the pulsatile hemodynamic parameters, only the baPWV was significantly reduced (from1537.78 ± 200.63 cm/s to 1460.06 ± 186.09 cm/s to 1456.53 ± 196.03 cm/s, p for trend = 0.016). The haPWV only decreased with borderline significance (from 1015.38 ± 124.26 cm/s to 978.88 ± 126.55 cm/s to 967.99 ± 103.37 cm/s, p for trend = 0.041). The other pulsatile hemodynamic parameters remained unchanged before and after therapy. Subgroup analysis (age above or below52 years) showed that the baPWVwas significantly reduced only in the younger group. CONCLUSIONS: Among the pulsatile hemodynamic parameters, only the baPWV was effectively reduced by either CCB or ARB. The improvement of PWV was more evident in younger subjects. KEY WORDS: Arterial stiffness; Central arterial pressure; Hypertension; Pulse wave velocity; Ventriculo-arterial coupling.
Authors: Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell Journal: Circulation Date: 2004-08-23 Impact factor: 29.690
Authors: Martin Osranek; John H Eisenach; Bijoy K Khandheria; Krishnaswamy Chandrasekaran; James B Seward; Marek Belohlavek Journal: Hypertension Date: 2007-12-24 Impact factor: 10.190
Authors: R Virmani; A P Avolio; W J Mergner; M Robinowitz; E E Herderick; J F Cornhill; S Y Guo; T H Liu; D Y Ou; M O'Rourke Journal: Am J Pathol Date: 1991-11 Impact factor: 4.307
Authors: Isla S Mackenzie; Carmel M McEniery; Zahid Dhakam; Morris J Brown; John R Cockcroft; Ian B Wilkinson Journal: Hypertension Date: 2009-06-01 Impact factor: 10.190
Authors: Enrico Agabiti-Rosei; Giuseppe Mancia; Michael F O'Rourke; Mary J Roman; Michel E Safar; Harold Smulyan; Ji-Guang Wang; Ian B Wilkinson; Bryan Williams; Charalambos Vlachopoulos Journal: Hypertension Date: 2007-06-11 Impact factor: 10.190